Current Environment: Production

Medical Services

Programs & Services

Languages

  • English

Education

Medical School

University of Southern California

1988, Los Angeles, CA

Internship

University of Colorado Health Sciences Center

1988, Denver, CO

Residency

Pediatrics

University of Colorado Health Sciences Center

1991, Denver, CO

Fellowship

Pediatric Emergency Medicine

Boston Children's Hospital

1994, Boston, MA

Certifications

  • American Board of Pediatrics (Emergency Medicine)

Publications

  1. Are we prepared to care for the children? An assessment of pediatric-specific pre-deployment training provided by non-governmental organizations operating in disaster zones. Am J Emerg Med. 2025 May; 91:25-28. View Abstract

  2. Pediatric Disaster Science: Understanding Needs, Highlighting Imperatives, and Leveraging Opportunities. NAM Perspect. 2024; 2024. View Abstract

  3. Development and evaluation of a novel knowledge assessment tool for pediatric emergency medicine clerkships. AEM Educ Train. 2024 Feb; 8(1):e10938. View Abstract

  4. Pediatric disaster preparedness curriculum across emergency medicine residencies. Am J Disaster Med. 2024 Winter; 19(1):53-58. View Abstract

  5. Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective. Am J Hematol. 2023 04; 98(4):620-627. View Abstract

  6. Pediatric Casualties in Terrorist Attacks: A Semi-Quantitative Analysis of Global Events. Prehosp Disaster Med. 2023 Feb; 38(1):11-16. View Abstract

  7. Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol. 2022 11; 97(11):E412-E415. View Abstract

  8. Emergency Laboratory Evaluations for Patients With Inborn Errors of Metabolism. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1154-e1159. View Abstract

  9. COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research. Pediatr Res. 2020 08; 88(2):148-150. View Abstract

  10. Rapid cycle deliberate practice vs. traditional simulation in a resource-limited setting. BMC Med Educ. 2019 Aug 22; 19(1):314. View Abstract

  11. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain. Am J Hematol. 2019 06; 94(6):689-696. View Abstract

  12. Health care system hazard vulnerability analysis: an assessment of all public hospitals in Abu Dhabi. Disasters. 2014 Apr; 38(2):420-33. View Abstract

  13. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials. 2013 Apr; 10(2):319-31. View Abstract

  14. Use of an automated case log to improve trainee evaluations on a pediatric emergency medicine rotation. Pediatr Emerg Care. 2013 Mar; 29(3):314-8. View Abstract

  15. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion. 2013 Apr; 53(4):704-9. View Abstract

  16. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol. 2011 Dec; 86(12):E70-3. View Abstract

  17. Response to challenges and lessons learned from Hurricanes Katrina and Rita: a national perspective. Pediatrics. 2011 Aug; 128 Suppl 1:S31-3. View Abstract

  18. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009 Mar; 52(3):369-72. View Abstract

  19. A simulator-based tool that assesses pediatric resident resuscitation competency. Pediatrics. 2008 Mar; 121(3):e597-603. View Abstract

  20. FEMA's organized response with a pediatric subspecialty team: the National Disaster Medical System response: a pediatric perspective. Pediatrics. 2006 May; 117(5 Pt 3):S405-11. View Abstract

  21. Advanced training in pediatric emergency medicine in the United States, Canada, United Kingdom, and Australia: an international comparison and resources guide. Ann Emerg Med. 2005 Mar; 45(3):269-75. View Abstract

  22. Monitoring participant safety in phase I and II interventional trials: options and controversies. J Investig Med. 2004 Nov; 52(7):446-52. View Abstract

  23. Hydroxyurea and sickle cell disease: a chance for every patient. JAMA. 2003 Apr 02; 289(13):1692-4. View Abstract

  24. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003 Mar 05; 289(9):1136-42. View Abstract

  25. Computerized recruiting for clinical trials in real time. Ann Emerg Med. 2003 Feb; 41(2):242-6. View Abstract

  26. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun. 2001 Aug; 69(8):5212-5. View Abstract

  27. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr. 2000 Jul; 137(1):73-7. View Abstract

  28. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000 Feb; 35(2):358-62. View Abstract

  29. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998 Nov; 35 ( Pt 6):745-53. View Abstract

  30. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1998 Jun; 31(7):1460-5. View Abstract

  31. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis. Crit Care Med. 1996 Sep; 24(9):1514-7. View Abstract

  32. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med. 1995 Sep; 23(9):1512-8. View Abstract

  33. Characterization of tumor-infiltrating lymphocytes from murine mammary adenocarcinomas. Anticancer Res. 1994 May-Jun; 14(3A):881-8. View Abstract

  34. Amino acids in amniotic fluid in the second trimester of gestation. Pediatr Res. 1985 Oct; 19(10):1021-4. View Abstract
BESbswy